|
End-of-day quote
Korea S.E.
01/10/2026
|
5-day change | 1st Jan Change | ||
| 8,260.00 KRW | +0.85% |
|
+1.35% | -26.64% |
| 21/09 | Englewood Lab, Inc.(KOSDAQ:A950140) dropped from S&P Global BMI Index | CI |
| 11/08 | Englewood Lab, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Company Valuation: Englewood Lab, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 99,141 | 1,70,864 | 1,01,127 | 2,64,839 | 1,35,499 | 2,23,712 |
| Change | - | 72.34% | -40.81% | 161.89% | -48.84% | 65.1% |
| Enterprise Value (EV) 1 | 1,11,906 | 1,89,873 | 1,15,151 | 2,59,973 | 1,27,057 | 2,00,892 |
| Change | - | 69.67% | -39.35% | 125.77% | -51.13% | 58.11% |
| P/E | 32.2x | 11.4x | 13.9x | 12.8x | 6.9x | 9.02x |
| PBR | 1.63x | 2.11x | 1.09x | 2.3x | 0.94x | 1.36x |
| PEG | - | 0x | -0.3x | 0x | -1.28x | 0.3x |
| Capitalization / Revenue | 0.72x | 1.06x | 0.67x | 1.28x | 0.74x | 1.03x |
| EV / Revenue | 0.82x | 1.18x | 0.76x | 1.26x | 0.7x | 0.93x |
| EV / EBITDA | 9.09x | 8.95x | 8.09x | 7.82x | 5.31x | 4.72x |
| EV / EBIT | 14.2x | 11.2x | 11.7x | 9.01x | 6.76x | 5.38x |
| EV / FCF | 24.2x | -11.3x | 493x | 16.7x | -26.8x | 20x |
| FCF Yield | 4.13% | -8.85% | 0.2% | 6% | -3.73% | 5% |
| Dividend per Share 2 | - | - | - | - | 100 | 201 |
| Rate of return | - | - | - | - | 1.47% | 1.79% |
| EPS 2 | 155.1 | 754.9 | 365.7 | 1,044 | 987.9 | 1,249 |
| Distribution rate | - | - | - | - | 10.1% | 16.1% |
| Net sales 1 | 1,37,168 | 1,60,816 | 1,51,509 | 2,06,784 | 1,82,220 | 2,16,790 |
| EBITDA 1 | 12,307 | 21,209 | 14,230 | 33,249 | 23,912 | 42,601 |
| EBIT 1 | 7,869 | 16,905 | 9,882 | 28,855 | 18,795 | 37,368 |
| Net income 1 | 3,082 | 14,997 | 7,265 | 20,742 | 19,628 | 24,815 |
| Net Debt 1 | 12,766 | 19,010 | 14,023 | -4,865 | -8,442 | -22,820 |
| Reference price 2 | 4,990.00 | 8,600.00 | 5,090.00 | 13,330.00 | 6,820.00 | 11,260.00 |
| Nbr of stocks (in thousands) | 19,868 | 19,868 | 19,868 | 19,868 | 19,868 | 19,868 |
| Announcement Date | 17/03/21 | 16/03/22 | 15/03/23 | 21/03/24 | 20/03/25 | 16/03/26 |
1KRW in Million2KRW
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 12Cr | |
| 21.15x | 4.04x | 14.79x | 3.05% | 33TCr | |
| 28.54x | 4.39x | 18.11x | 2.09% | 22TCr | |
| 17.74x | 2.66x | 11.72x | 3.6% | 13TCr | |
| 23.26x | 3.46x | 14.55x | 2.51% | 6.74TCr | |
| 49.91x | 7.23x | 27.86x | 0.31% | 4.51TCr | |
| 38.12x | 6.13x | 26.61x | 2.45% | 4.48TCr | |
| 18.14x | 2.58x | 10.74x | 4.9% | 3.31TCr | |
| 31.19x | 2.36x | 13.24x | 1.73% | 3.26TCr | |
| 14.14x | 2.31x | 10.68x | 5.47% | 3.14TCr | |
| Average | 26.91x | 3.91x | 16.48x | 2.9% | 9.4TCr | |
| Weighted average by Cap. | 24.79x | 3.98x | 16.00x | 2.8% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- A950140 Stock
- Valuation Englewood Lab, Inc.
Select your edition
All financial news and data tailored to specific country editions
